Anti-human immunodeficiency virus agent 3'-azido-3'-deoxythymidine inhibits replication of Epstein-Barr virus
- PMID: 2834997
- PMCID: PMC172149
- DOI: 10.1128/AAC.32.2.265
Anti-human immunodeficiency virus agent 3'-azido-3'-deoxythymidine inhibits replication of Epstein-Barr virus
Abstract
We show that the anti-human immunodeficiency virus agent, 3'-azido-3'-deoxythymidine (AZT), which suppresses infectivity and cytopathic effects of human immunodeficiency virus, also effectively inhibits Epstein-Barr virus (EBV) DNA replication. However, AZT has no effect on four other human herpesviruses: cytomegalovirus, varicella-zoster virus, and herpes simplex virus types 1 and 2. The combination of acyclovir and AZT, while it is not synergistic, has an additive effect against EBV replication. AZT may prove to be a useful drug for treatment of coinfections with human immunodeficiency virus and EBV.
Similar articles
-
Effect of ara-T on the replication of herpes simplex virus, varicella-zoster virus and cytomegalovirus.IARC Sci Publ (1971). 1978;(24 Pt 2):991-7. IARC Sci Publ (1971). 1978. PMID: 221418
-
Differential effect of arabinofuranosylthymine of the replication of human herpesviruses.J Virol. 1977 Sep;23(3):679-84. doi: 10.1128/JVI.23.3.679-684.1977. J Virol. 1977. PMID: 197264 Free PMC article.
-
Suppression of human immunodeficiency virus replication by 3'-azido-3'-deoxythymidine in various human hematopoietic cell lines in vitro: augmentation of the effect by lentinan.Jpn J Cancer Res. 1987 Jun;78(6):583-9. Jpn J Cancer Res. 1987. PMID: 3112074
-
Perspectives on interactions of acyclovir with Epstein-Barr and other herpes viruses.Am J Med. 1982 Jul 20;73(1A):18-26. doi: 10.1016/0002-9343(82)90057-2. Am J Med. 1982. PMID: 6285710 Review.
-
The spectrum of antiviral activities of acyclovir in vitro and in vivo.J Antimicrob Chemother. 1983 Sep;12 Suppl B:19-27. doi: 10.1093/jac/12.suppl_b.19. J Antimicrob Chemother. 1983. PMID: 6313598 Review.
Cited by
-
Sequential serological studies of homosexual men with and without HIV infection. Epstein-Barr virus activation preceding and following HIV seroconversion.Clin Exp Immunol. 1991 Aug;85(2):209-13. doi: 10.1111/j.1365-2249.1991.tb05706.x. Clin Exp Immunol. 1991. PMID: 1650655 Free PMC article.
-
Zidovudine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.Drugs. 1989 Apr;37(4):408-50. doi: 10.2165/00003495-198937040-00003. Drugs. 1989. PMID: 2661194 Review.
-
Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.J Virol. 2019 Nov 26;93(24):e00980-19. doi: 10.1128/JVI.00980-19. Print 2019 Dec 15. J Virol. 2019. PMID: 31578295 Free PMC article.
-
Two treatment strategies for management of Neurosymptomatic cerebrospinal fluid HIV escape in Pune, India.Medicine (Baltimore). 2020 Jun 12;99(24):e20516. doi: 10.1097/MD.0000000000020516. Medicine (Baltimore). 2020. PMID: 32541474 Free PMC article.
-
Human herpesvirus 8 open reading frame 21 is a thymidine and thymidylate kinase of narrow substrate specificity that efficiently phosphorylates zidovudine but not ganciclovir.J Virol. 2000 Jan;74(2):684-92. doi: 10.1128/jvi.74.2.684-692.2000. J Virol. 2000. PMID: 10623730 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources